Table 2.
Study | Hepatic | Neuropsychiatric | Presymptomatic | Other |
---|---|---|---|---|
Lee et al (n = 245)69 | 134 (54.8%) | 55 (22.4%) | 55 (22.4%) | 1 (0.4%) (osseomuscular) |
Taly et al (n = 282)42 | 42 (15%) | 219 (77.6%) Neuro, 195; hepato-neuro, 10; psychiatric, 7; others, 7 |
15 (5.4%) | 6 (2%) (osseomuscular) |
Walshe (n = 217)40 | 94 (43.1%) | 97 (44%) | 24 (11%) | 2 (0.9%) (osseomuscular) |
Cheng et al (n = 1222)70 | 450 (37%) | 592 (48.5%) | 31 (2.5%) | 149 (12%) (neurovisceral) |